Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet

NCT02238223 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2001

Last updated 2014-09-12

No results posted yet for this study

Summary

Study to investigate the safety and efficacy information of Alesion® Tablet under the proper use in daily clinical practice after new treatment guideline for allergic rhinitis, bronchial asthma, eczema, dermatitis, urticaria, pruritus, prurigo and psoriasis vulgaris with itching

Conditions

  • Rhinitis, Allergic, Perennial

Interventions

DRUG

Alesion®

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2006-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02238223 on ClinicalTrials.gov